Govindraj Prasanthi, West Leigh, Smith Simone, Hassell John R
Center for Research in Skeletal Development and Pediatric Orthopaedics, Shriners Hospitals for Children, Tampa, FL 33612, USA.
Matrix Biol. 2006 May;25(4):232-9. doi: 10.1016/j.matbio.2006.01.003. Epub 2006 Feb 14.
FGF-2 is a regulator of chondrocyte proliferation in the developing growth plate and has been shown to bind to perlecan, a heparan sulfate proteoglycan. We evaluated the effect of perlecan isolated from the growth plate on the binding of FGF-2 to its low and high affinity receptors on resting and proliferating chondrocytes. Chondrocytes were isolated by pronase/collagenase digestion of 1 mm thick slices from the resting and proliferating zones of fetal bovine ribs and were plated in serum-free DMEM. Chondrocytes maintained their zone-specific level of DNA and matrix synthesis over a two-day culture period. The collagen, aggrecan, and perlecan components of the matrix produced were associated with the cell layer and were secreted into the medium. Most of the perlecan made by the chondrocytes was secreted into the medium. Western blots showed medium perlecan to contain two high molecular weight core proteins and overlay assays showed only the large core protein bound FGF-2. Cell layer perlecan contained only the smaller core protein. Immunoprecipitation assays of media showed that the medium perlecan bound (125)I-FGF-2, that the bound FGF-2 was eluted from perlecan by 2 M NaCl at pH 7.4, and that this binding was eliminated by prior digestion with heparatinase. This indicates that the perlecan secreted into the medium is a low affinity receptor for FGF-2. (125)I-FGF-2 also bound to the chondrocytes in cell culture. Competition studies showed exogenous FGF-2 reduced (125)I-FGF-2 binding to high affinity receptor but not the low affinity receptor in the cell layer. Exogenous perlecan, however, reduced (125)I-FGF-2 binding to both the low and the high affinity receptors in the cell layer by approximately 60%. The results suggest that perlecan made by growth plate chondrocytes is a low affinity receptor for FGF-2 and acts to sequester FGF-2 away from the high affinity receptor.
成纤维细胞生长因子-2(FGF-2)是发育中的生长板中软骨细胞增殖的调节因子,且已证明它能与硫酸乙酰肝素蛋白聚糖核心蛋白聚糖结合。我们评估了从生长板分离出的核心蛋白聚糖对FGF-2与其在静止及增殖软骨细胞上的低亲和力和高亲和力受体结合的影响。通过用链霉蛋白酶/胶原酶消化取自胎牛肋骨静止区和增殖区的1毫米厚切片来分离软骨细胞,并将其接种于无血清的 Dulbecco改良 Eagle培养基(DMEM)中。在为期两天的培养期内,软骨细胞维持其区域特异性的DNA和基质合成水平。所产生基质的胶原蛋白、聚集蛋白聚糖和核心蛋白聚糖成分与细胞层相关并分泌到培养基中。软骨细胞产生的大部分核心蛋白聚糖分泌到了培养基中。蛋白质免疫印迹显示培养基中的核心蛋白聚糖含有两种高分子量核心蛋白,而覆盖分析表明只有较大的核心蛋白能结合FGF-2。细胞层中的核心蛋白聚糖仅含有较小的核心蛋白。对培养基进行免疫沉淀分析表明,培养基中的核心蛋白聚糖能结合碘(125)标记的FGF-2,结合的FGF-2在pH 7.4条件下被2 M氯化钠从核心蛋白聚糖上洗脱下来,且这种结合可通过事先用肝素酶消化而消除。这表明分泌到培养基中的核心蛋白聚糖是FGF-2的低亲和力受体。碘(125)标记的FGF-2在细胞培养中也能与软骨细胞结合。竞争研究表明,外源性FGF-2可降低碘(125)标记的FGF-2与细胞层中高亲和力受体的结合,但不影响其与低亲和力受体的结合。然而,外源性核心蛋白聚糖可使碘(125)标记的FGF-2与细胞层中低亲和力和高亲和力受体的结合减少约60%。结果表明,生长板软骨细胞产生的核心蛋白聚糖是FGF-2的低亲和力受体,其作用是将FGF-2从高亲和力受体处隔离。